N
NovaBay Pharmaceuticals, Inc. (NBY)
ASE – Real Time Price. Currency in USD
1.95
+0.36 (22.64%)
At close: Apr 2, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
1.95
+0.36 (22.64%)
At close: Apr 2, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $18.4M significantly exceed its total debt $637.0K, ensuring strong financial flexibility
Total current assets $18.9M exceed Total current liabilities $3.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-128.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.29 | 6.05 | 10 | |
| Quick ratio | 5.29 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | -128.33 | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 14M | 10M | N/A | N/A | 3M |
| Gross Profit | 8M | 6M | -341K | -140K | -51K |
| Operating Income | -8M | -4M | -7M | -8M | -6M |
| Net Income | -16M | -6M | -7M | -642M | 546M |
| EBITDA | -7M | -4M | -7M | -7M | -6M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | 47.83 | 5.5 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 372.74 | 42822.58 | N/A | 1.96 | 6.0 |
| Y/Y | 999 | 45677.81 | 61.67 | -15.71 | 7.8 |
| 3y average | 290.53 | -2914.42 | 79.48 | -16.94 | 5.5 |
| 5y average | 183.1 | -1775.06 | 29.55 | -23.15 | 5.5 |
| Weighted average score | 6.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | 0.00 | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | 0.00 | 0.00 | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |